Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer
Open Access
- 25 February 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 7 (2), e2111
- https://doi.org/10.1038/cddis.2015.403
Abstract
Growth factor-induced activation of protein kinase-B (PKB), also known as AKT, induces pro-survival signaling and inhibits activation of pro-apoptotic signaling molecules including the Forkhead box O-3a (FOXO3a) transcription factor and caspase in transformed prostate cells in vitro. Earlier we reported that Withaferin-A (WA), a small herbal molecule, induces pro-apoptotic response-4 (Par-4) mediated apoptosis in castration-resistant prostate cancer (CRPC) cells. In the present study, we demonstrate that inhibition of AKT facilitates nuclear shuttling of FOXO3a where it regulates Par-4 transcription in CRPC cells. FOXO3a is upstream of Par-4 signaling, which is required for induction of apoptosis in CRPC cells. Promoter bashing studies and Ch-IP analysis confirm a direct interaction of FOXO3a and Par-4; a sequential deletion of FOXO3a-binding sites in the Par-4 promoter fails to induce Par-4 activation. To confirm these observations, we either overexpressed AKT or silenced FOXO3a activation in CRPC cells. Both methods inhibit Par-4 function and apoptosis is significantly compromised. In xenograft tumors derived from AKT-overexpressed CRPC cells, FOXO3a and Par-4 expression is downregulated, leading to aggressive tumor growth. Oral administration of WA to mice with xenograft tumors restores FOXO3a-mediated Par-4 functions and results in inhibited tumor growth. Finally, an inverse correlation of nuclear localization of AKT expression corresponds to cytoplasmic Par-4 localization in human prostate tissue array. Our studies suggest that Par-4 is one of the key transcriptional targets of FOXO3a, and Par-4 activation is required for induction of apoptosis in CRPC cells. Activation of FOXO3a appears to be an attractive target for the treatment of CRPC and molecules such as WA can be explored further for the treatment of CRPC.Keywords
This publication has 52 references indexed in Scilit:
- IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic FunctionPLOS ONE, 2013
- FoxO3a is activated and executes neuron death via Bim in response to β-amyloidCell Death & Disease, 2013
- Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancerMolecular Biology of the Cell, 2012
- Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid LeukemiaClinical Cancer Research, 2010
- The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for ApoptosisCell, 2009
- A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in CancerClinical Cancer Research, 2009
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populationsProceedings of the National Academy of Sciences of the United States of America, 2009
- Withaferin A Causes FOXO3a- and Bim-Dependent Apoptosis and Inhibits Growth of Human Breast Cancer Cells In vivoCancer Research, 2008
- Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesisThe EMBO Journal, 2008
- Dynamic FoxO transcription factorsJournal of Cell Science, 2007